Cell based in vitro and ex vivo models in metabolic disease drug discovery: nice to have or critical path?

Hallén, Stefan; Clapham, John C.

Affiliation

Hallén S; Departments of Bioscience, AstraZeneca R&D Mölndal, Sweden +46 31 7064339 ; +46 31 7763700 ; stefan.hallen@astrazeneca.com.

Expert Opin Drug Discov ; 4(4): 417-28, 2009 Apr.

Article in En | MEDLINE | ID: mdl-23485042

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2009 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies Language: En Year: 2009 Type: Article